Dr. Jeffrey R. Jay, M.D. as of June 30, 2012
Portfolio Holdings for Dr. Jeffrey R. Jay, M.D.
Dr. Jeffrey R. Jay, M.D. holds 31 positions in its portfolio as reported in the June 2012 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| OncoGenex Pharmaceuticals | 10.1 | $9.9M | 734k | 13.44 | |
| Oncothyreon | 9.3 | $9.1M | 2.0M | 4.68 | |
| Santarus | 8.0 | $7.9M | 1.1M | 7.09 | |
| Insulet Corporation (PODD) | 7.6 | $7.5M | 350k | 21.37 | |
| Rigel Pharmaceuticals | 6.8 | $6.7M | 720k | 9.30 | |
| China Kanghui Holdings | 6.5 | $6.4M | 325k | 19.70 | |
| Abiomed | 6.4 | $6.3M | 275k | 22.82 | |
| Vanda Pharmaceuticals (VNDA) | 5.5 | $5.4M | 1.2M | 4.40 | |
| Osiris Therapeutics | 4.0 | $3.9M | 358k | 11.00 | |
| Biodel | 3.6 | $3.5M | 1.4M | 2.58 | |
| Pain Therapeutics | 3.1 | $3.1M | 651k | 4.69 | |
| Targacept | 3.0 | $3.0M | 688k | 4.30 | |
| Amarin Corporation (AMRN) | 3.0 | $2.9M | 204k | 14.46 | |
| Aastrom Biosciences | 2.4 | $2.4M | 1.1M | 2.15 | |
| INC Ventrus Biosciences | 2.4 | $2.3M | 539k | 4.27 | |
| RTI Biologics | 1.9 | $1.9M | 500k | 3.76 | |
| ACADIA Pharmaceuticals (ACAD) | 1.8 | $1.8M | 1.0M | 1.76 | |
| Palatin Technologies | 1.7 | $1.6M | 3.3M | 0.50 | |
| NPS Pharmaceuticals | 1.6 | $1.6M | 180k | 8.61 | |
| Dex (DXCM) | 1.5 | $1.5M | 115k | 12.96 | |
| Spectranetics Corporation | 1.4 | $1.4M | 120k | 11.42 | |
| Synergetics USA | 1.3 | $1.3M | 294k | 4.46 | |
| Cardica | 1.3 | $1.3M | 695k | 1.88 | |
| Columbia Laboratories | 1.3 | $1.3M | 1.9M | 0.68 | |
| Trius Therapeutics | 1.2 | $1.2M | 200k | 5.76 | |
| Merit Medical Systems (MMSI) | 1.0 | $967k | 70k | 13.81 | |
| Alphatec Holdings | 0.9 | $925k | 503k | 1.84 | |
| Discovery Laboratories | 0.8 | $823k | 355k | 2.32 | |
| Tengion | 0.3 | $266k | 90k | 2.95 | |
| Repligen Corporation (RGEN) | 0.1 | $68k | 16k | 4.33 | |
| AMAG Pharmaceuticals | 0.0 | $2.0k | 150.00 | 13.33 |
